Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Jenkins RG"" wg kryterium: Autor


Tytuł:
The impact of hiatus hernia in hypersensitivity pneumonitis.
Autorzy:
Heriot DA; Imperial College School of Medicine, London, UK.
Stock CJW; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Mumtaz ZU; Imperial College School of Medicine, London, UK.
Jenkins RG; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Chua F; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Molyneaux PL; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Devaraj A; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Kouranos V; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Wells AU; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Renzoni EA; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Padley SPG; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Desai SR; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
George PM; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.
Pokaż więcej
Źródło:
Respirology (Carlton, Vic.) [Respirology] 2024 Mar 13. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis.
Autorzy:
Guillen-Guio B; Department of Population Health Sciences, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Leicester, UK.; Joint first authors.
Paynton ML; Department of Population Health Sciences, University of Leicester, Leicester, UK.; Joint first authors.
Allen RJ; Department of Population Health Sciences, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Leicester, UK.
Chin DPW; Department of Population Health Sciences, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Leicester, UK.
Donoghue LJ; Genentech, San Francisco, CA, USA.
Stockwell A; Genentech, San Francisco, CA, USA.
Leavy OC; Department of Population Health Sciences, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Leicester, UK.
Hernandez-Beeftink T; Department of Population Health Sciences, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Leicester, UK.
Reynolds C; National Heart & Lung Institute, Imperial College London, London, UK.
Cullinan P; National Heart & Lung Institute, Imperial College London, London, UK.
Martinez F; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Booth HL; University College Hospital, University College London, London, UK.
Fahy WA; GlaxoSmithKline, London, UK.
Hall IP; School of Medicine, University of Nottingham, Nottingham, UK.; National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK.
Hart SP; Hull York Medical School, University of Hull, Hull, UK.
Hill MR; MRC Population Health Unit, University of Oxford, Oxford, UK.
Hirani N; Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
Hubbard RB; School of Medicine, University of Nottingham, Nottingham, UK.; National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham, UK.
McAnulty RJ; Division of Medicine, University College London, London, UK.
Millar AB; Bristol Medical School, University of Bristol, Bristol, UK.
Navaratnam V; Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.; National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.; Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, QLD, Australia.
Oballa E; GlaxoSmithKline, London, UK.
Parfrey H; Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
Saini G; School of Medicine, University of Nottingham, Nottingham, UK.
Sayers I; Centre for Respiratory Research, NIHR Nottingham Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK.
Tobin MD; Department of Population Health Sciences, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Leicester, UK.
Whyte MKB; Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
Adegunsoye A; Department of Medicine, University of Chicago, Chicago, IL, USA.
Kaminski N; Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Ma SF; Department of Medicine, University of Virginia, Charlottesville, VA, USA.
Strek ME; Department of Medicine, University of Chicago, Chicago, IL, USA.
Zhang Y; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Fingerlin TE; Department of Immunology and Genomic Medicine, National Jewish Health, Denver, CO, USA.
Molina-Molina M; Servei de Pneumologia, Laboratori de Pneumologia Experimental, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.; Campus de Bellvitge, Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Neighbors M; Genentech, San Francisco, CA, USA.
Sheng XR; Genentech, San Francisco, CA, USA.
Oldham JM; Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.
Maher TM; National Heart and Lung Institute, Imperial College London, London, UK.; Division of Pulmonary and Critical Care Medicine, University of Southern California, Los Angeles, USA.
Molyneaux PL; National Heart and Lung Institute, Imperial College London, London, UK.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Flores C; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.; Research Unit, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.; Genomics Division, Instituto Tecnologico y de Energias Renovables, Santa Cruz de Tenerife, Spain.; Facultad de Ciencias de la Salud, Universidad Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain.
Noth I; Department of Medicine, University of Virginia, Charlottesville, VA, USA.
Schwartz DA; Department of Medicine, University of Colorado, Anscuhtz, CO, USA.
Yaspan BL; Genentech, San Francisco, CA, USA.
Jenkins RG; National Heart and Lung Institute, Imperial College London, London, UK.
Wain LV; Department of Population Health Sciences, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Leicester, UK.; Joint senior authors.
Hollox EJ; Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.; Joint senior authors.
Pokaż więcej
Źródło:
ERJ open research [ERJ Open Res] 2024 Feb 19; Vol. 10 (1). Date of Electronic Publication: 2024 Feb 19 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertension.
Autorzy:
Parcesepe G; Department of Population Health Sciences, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Leicester, UK.
Allen RJ; Department of Population Health Sciences, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Leicester, UK.
Guillen-Guio B; Department of Population Health Sciences, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Leicester, UK.
Moss S; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK.
Jenkins RG; Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK.
Wain LV; Department of Population Health Sciences, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Leicester, UK.
Pokaż więcej
Źródło:
ERJ open research [ERJ Open Res] 2023 Nov 13; Vol. 9 (6). Date of Electronic Publication: 2023 Nov 13 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis.
Autorzy:
May J
Mitchell JA
Jenkins RG
Pokaż więcej
Źródło:
The Journal of clinical investigation [J Clin Invest] 2023 Sep 15; Vol. 133 (18). Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Idiopathic Pulmonary Fibrosis*
Drug-Related Side Effects and Adverse Reactions*
Humans ; Endothelial Cells ; Cicatrix ; Epoprostenol
Czasopismo naukowe
Tytuł:
Contemporary Concise Review 2022: Interstitial lung disease.
Autorzy:
Smith DJF; National Heart and Lung Institute, Imperial College London, London, UK.; Department of Interstitial Lung Disease, Royal Brompton and Harefield Hospital, Guys and St Thomas' NHS Foundation Trust, London, UK.
Jenkins RG; National Heart and Lung Institute, Imperial College London, London, UK.; Department of Interstitial Lung Disease, Royal Brompton and Harefield Hospital, Guys and St Thomas' NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło:
Respirology (Carlton, Vic.) [Respirology] 2023 Jul; Vol. 28 (7), pp. 627-635. Date of Electronic Publication: 2023 Apr 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*
Lung Diseases, Interstitial*/diagnosis
Idiopathic Pulmonary Fibrosis*/diagnosis
Idiopathic Pulmonary Fibrosis*/genetics
Idiopathic Pulmonary Fibrosis*/therapy
Alveolitis, Extrinsic Allergic*
Humans ; Disease Progression ; Lung/diagnostic imaging
Czasopismo naukowe
Tytuł:
The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis.
Autorzy:
Stephenson KE; Division of Respiratory Medicine, School of Medicine, University of Nottingham, Nottingham, UK. .; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. .
Porte J; Division of Respiratory Medicine, School of Medicine, University of Nottingham, Nottingham, UK.
Kelly A; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Wallace WA; Division of Pathology, University of Edinburgh, Edinburgh, UK.
Huntington CE; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK.
Overed-Sayer CL; Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Cohen ES; Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Jenkins RG; National Heart and Lung Institute, Imperial College London, London, UK.; Margaret Turner Warwick Centre for Fibrosing Lung Disease, Imperial College London, London, UK.; Interstitial lung disease unit, Royal Brompton Hospital, London, UK.
John AE; Division of Respiratory Medicine, School of Medicine, University of Nottingham, Nottingham, UK.; National Heart and Lung Institute, Imperial College London, London, UK.; Margaret Turner Warwick Centre for Fibrosing Lung Disease, Imperial College London, London, UK.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2023 Mar 23; Vol. 24 (1), pp. 89. Date of Electronic Publication: 2023 Mar 23.
Typ publikacji:
Journal Article
MeSH Terms:
Idiopathic Pulmonary Fibrosis*/chemically induced
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/metabolism
Interleukin-33*/metabolism
Animals ; Humans ; Mice ; Bleomycin/toxicity ; Fibroblasts/metabolism ; Interleukin-1 Receptor-Like 1 Protein/genetics ; Lung/metabolism ; Mice, Inbred C57BL ; Transforming Growth Factor beta/metabolism
Czasopismo naukowe
Tytuł:
Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohort.
Autorzy:
Fainberg HP; National Heart and Lung Institute, Imperial College London, London, UK. Electronic address: .
Oldham JM; Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.
Molyneau PL; National Heart and Lung Institute, Imperial College London, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Allen RJ; Department of Health Sciences, University of Leicester, Leicester, UK.
Kraven LM; Department of Health Sciences, University of Leicester, Leicester, UK.
Fahy WA; Discovery Medicine, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
Porte J; Nottingham Respiratory Research Unit, NIHR Biomedical Research Centre, University of Nottingham, Nottingham, UK.
Braybrooke R; Nottingham Respiratory Research Unit, NIHR Biomedical Research Centre, University of Nottingham, Nottingham, UK.
Saini G; Nottingham Respiratory Research Unit, NIHR Biomedical Research Centre, University of Nottingham, Nottingham, UK.
Karsdal MA; Nordic Bioscience, Herlev, Denmark.
Leeming DJ; Nordic Bioscience, Herlev, Denmark.
Sand JMB; Nordic Bioscience, Herlev, Denmark.
Triguero I; Computational Optimisation and Learning Lab, School of Computer Science, University of Nottingham, Nottingham, UK; DaSCI Andalusian Institute in Data Science and Computational Intelligence, University of Granada, Granada, Spain.
Oballa E; Discovery Medicine, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
Wells AU; National Heart and Lung Institute, Imperial College London, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Renzoni E; National Heart and Lung Institute, Imperial College London, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Wain LV; Department of Health Sciences, University of Leicester, Leicester, UK; National Institute for Health Research, Leicester Respiratory Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
Noth I; Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, VA, USA.
Maher TM; National Heart and Lung Institute, Imperial College London, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Stewart ID; National Heart and Lung Institute, Imperial College London, London, UK.
Jenkins RG; National Heart and Lung Institute, Imperial College London, London, UK; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło:
The Lancet. Digital health [Lancet Digit Health] 2022 Dec; Vol. 4 (12), pp. e862-e872. Date of Electronic Publication: 2022 Nov 01.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Idiopathic Pulmonary Fibrosis*/drug therapy
Idiopathic Pulmonary Fibrosis*/genetics
Humans ; Prospective Studies ; Vital Capacity ; Cohort Studies ; Biomarkers
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies